Published in J Clin Invest on February 01, 1980
Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med (1989) 7.72
Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J Clin Invest (1985) 3.98
Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J Clin Invest (1988) 3.69
EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci U S A (1990) 2.94
Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J Clin Invest (1990) 2.91
Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest (1986) 2.76
Sites of inhibition of mitochondrial electron transport in macrophage-injured neoplastic cells. J Cell Biol (1982) 2.54
Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J (1993) 1.83
Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J Virol (1995) 1.74
Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol (1997) 1.40
Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig Dis Sci (1997) 1.33
Extracellular superoxide dismutase, nitric oxide, and central nervous system O2 toxicity. Proc Natl Acad Sci U S A (1992) 1.31
An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality. Mol Med (1995) 1.31
Cryptococcus neoformans requires a functional glycolytic pathway for disease but not persistence in the host. MBio (2011) 1.29
Expression of the adenovirus E1A oncogene during cell transformation is sufficient to induce susceptibility to lysis by host inflammatory cells. Proc Natl Acad Sci U S A (1986) 1.19
Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites. J Exp Med (1995) 1.11
Cytostatic and cytotoxic effects of activated macrophages and nitric oxide donors on Brugia malayi. Infect Immun (1997) 1.07
Inhibition of mitochondrial protein synthesis results in increased endothelial cell susceptibility to nitric oxide-induced apoptosis. Proc Natl Acad Sci U S A (2002) 0.93
Potential role of nitric oxide in the pathophysiology of experimental bacterial meningitis in rats. Infect Immun (1995) 0.88
Korean Red Ginseng protects endothelial cells from serum-deprived apoptosis by regulating Bcl-2 family protein dynamics and caspase S-nitrosylation. J Ginseng Res (2013) 0.82
Nitric oxide derived from L-arginine impairs cytoplasmic pH regulation by vacuolar-type H+ ATPases in peritoneal macrophages. J Exp Med (1991) 0.81
The L-arginine/nitric oxide pathway--biological properties and therapeutic applications. Ulster Med J (1994) 0.75
Production of reactive nitrogen intermediates by bone marrow-derived macrophages on treatment with cisplatin in vitro. Clin Exp Immunol (1992) 0.75
Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J Exp Med (1979) 5.38
Localization of the primary metabolic block produced by 2-deoxyglucose. J Biol Chem (1957) 4.79
The concept of the activated macrophage. J Immunol (1978) 3.69
Activated macrophages kill tumour cells by releasing arginase. Nature (1978) 3.63
Macrophage tumor killing: influence of the local environment. Science (1977) 2.94
Characterization of the effects of endotoxin on macrophage tumor cell killing. J Immunol (1978) 2.65
Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni. J Infect Dis (1971) 2.58
EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA. Cancer Chemother Rep (1964) 2.55
Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells. J Exp Med (1978) 2.03
Heterocytolysis by macrophages activated by bacillus Calmette-Guérin: lysosome exocytosis into tumor cells. Science (1974) 1.85
Differential stimulation of murine lymphoma growth in vitro by normal and BCG-activated macrophages. J Exp Med (1975) 1.77
Synthesis and release of thymidine by macrophages. J Immunol (1977) 1.77
The role of activated macrophages in specific and nonspecific cytostasis of tumor cells. J Immunol (1974) 1.56
Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effects. Clin Exp Immunol (1978) 1.46
Bioenergetics and the problem of tumor growth. Am Sci (1972) 1.42
IN VITRO CYTOTOXIC EFFECT OF ISOANTIBODY MEASURED AS ISOTOPE RELEASE FROM LABELLED TARGET CELL DNA. Nature (1963) 1.38
Effects of lysozyme on normal and transformed mammalian cells. Nature (1973) 1.33
Energy metabolism in respiration-deficient and wild type Chinese hamster fibroblasts in culture. J Cell Physiol (1976) 1.19
Cytokinetic studies of the effects of activated macrophages on tumor target cells. J Natl Cancer Inst (1975) 1.08
Effect of 2-deoxy-D-glucose on the cell-surface glycoproteins of hamster fibroblasts,. Eur J Biochem (1977) 1.04
Promitochondria of anaerobically grown yeast. V. Energy transfer in the absence of an electron transfer chain. Proc Natl Acad Sci U S A (1971) 0.98
A respiration-deficient Chinese hamster cell line with a defect in NADH-coenzyme Q reductase. J Biol Chem (1976) 0.95
Conditionally lethal mutations in chinese hamster cells. Characterization of a cell line with a possible defect in the Krebs cycle. J Cell Physiol (1975) 0.88
Glycolytic and respiratory properties of intact mammalian cells: inhibitor studies. Arch Biochem Biophys (1968) 0.85
Metabolism of ascites tumor cells. I. Rate of glycolysis and competitive utilization of fructose, mannose, and glucose. Cancer Res (1959) 0.82
Assay of immune cytolysis of lymphocytes and tumour cells by automatic determination of cell volume distribution. Immunology (1977) 0.81
Genetic determination of the mitochondrial adenine nucleotide translocation system and its role in the eukaryotic cell. Mol Cell Biochem (1977) 0.81
Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science (1987) 8.98
Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun (1988) 8.17
L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol (1987) 6.93
Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol (1991) 6.92
Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem (1999) 4.77
Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol (1990) 4.62
Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol (1990) 4.36
Histopathology of common tendinopathies. Update and implications for clinical management. Sports Med (1999) 4.16
Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol (1988) 4.04
Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J Clin Invest (1985) 3.98
Control of carcinogenesis: a possible role for the activated macrophage. Science (1972) 3.69
Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J Clin Invest (1988) 3.69
EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci U S A (1990) 2.94
Macrophage tumor killing: influence of the local environment. Science (1977) 2.94
Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J Clin Invest (1990) 2.91
Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest (1986) 2.76
Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med (1996) 2.75
Characterization of the effects of endotoxin on macrophage tumor cell killing. J Immunol (1978) 2.65
Urinary nitrate excretion in relation to murine macrophage activation. Influence of dietary L-arginine and oral NG-monomethyl-L-arginine. J Immunol (1991) 2.60
Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni. J Infect Dis (1971) 2.58
Sites of inhibition of mitochondrial electron transport in macrophage-injured neoplastic cells. J Cell Biol (1982) 2.54
Reporter genes: application to the study of mammalian gene transcription. Anal Biochem (1990) 2.51
Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest (1999) 2.44
Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance. Nat New Biol (1972) 2.44
The VISA score: an index of severity of symptoms in patients with jumper's knee (patellar tendinosis). Victorian Institute of Sport Tendon Study Group. J Sci Med Sport (1998) 2.27
Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect Immun (1991) 2.23
Studies of surgical outcome after patellar tendinopathy: clinical significance of methodological deficiencies and guidelines for future studies. Victorian Institute of Sport Tendon Study Group. Scand J Med Sci Sports (2000) 2.18
L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae. J Immunol (1991) 2.15
Macrophage nonimmunologic recognition: target cell factors related to contact inhibition. Science (1973) 2.09
Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity. J Immunol (1986) 2.06
The VISA-A questionnaire: a valid and reliable index of the clinical severity of Achilles tendinopathy. Br J Sports Med (2001) 2.06
Patellar tendinosis (jumper's knee): findings at histopathologic examination, US, and MR imaging. Victorian Institute of Sport Tendon Study Group. Radiology (1996) 1.95
Nitric oxide produced during murine listeriosis is protective. Infect Immun (1994) 1.93
Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am Rev Respir Dis (1990) 1.90
Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J Immunol (1993) 1.88
Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells. J Infect Dis (1987) 1.85
Heterocytolysis by macrophages activated by bacillus Calmette-Guérin: lysosome exocytosis into tumor cells. Science (1974) 1.85
Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor. Cell (1982) 1.84
Time to abandon the "tendinitis" myth. BMJ (2002) 1.76
Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway. Curr Pharm Des (2003) 1.74
The L-arginine dependent effector mechanism is induced in murine adenocarcinoma cells by culture supernatant from cytotoxic activated macrophages. J Leukoc Biol (1988) 1.72
Eccentric decline squat protocol offers superior results at 12 months compared with traditional eccentric protocol for patellar tendinopathy in volleyball players. Br J Sports Med (2005) 1.70
Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol (1996) 1.67
Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice. Infect Immun (1993) 1.65
Discrimination between neoplastic and non-neoplastic cells in vitro by activated macrophages. J Natl Cancer Inst (1974) 1.64
Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages. Biochem Biophys Res Commun (1984) 1.64
A pilot study of the eccentric decline squat in the management of painful chronic patellar tendinopathy. Br J Sports Med (2004) 1.62
Host response to adenovirus 2-transformed hamster embryo cells. Cancer Res (1979) 1.61
Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat. Gut (1985) 1.58
Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methods. Antimicrob Agents Chemother (1985) 1.55
Endocytosis of red blood cells or haemoglobin by activated macrophages inhibits their tumoricidal effect. Nature (1977) 1.55
Low-intensity pulsed ultrasound for chronic patellar tendinopathy: a randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) (2008) 1.53
Relationship of anatomic disease to appropriateness ratings of coronary angiography. Arch Intern Med (1995) 1.52
Patellar tendinopathy: some aspects of basic science and clinical management. Br J Sports Med (1998) 1.51
Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells. Infect Immun (1993) 1.50
Cytokines induce an L-arginine-dependent effector system in nonmacrophage cells. J Leukoc Biol (1988) 1.46
Tendon structure changes after maximal exercise in the Thoroughbred horse: use of ultrasound tissue characterisation to detect in vivo tendon response. Vet J (2012) 1.45
Where is the pain coming from in tendinopathy? It may be biochemical, not only structural, in origin. Br J Sports Med (2000) 1.44
Mitochondrial iron loss from leukemia cells injured by macrophages. A possible mechanism for electron transport chain defects. J Immunol (1988) 1.41
Correlation of ultrasound and magnetic resonance imaging with clinical outcome after patellar tenotomy: prospective and retrospective studies. Victorian Institute of Sport Tendon Study Group. Clin J Sport Med (1999) 1.41
Mouse macrophages stimulated by recombinant gamma interferon to kill tumor cells are not bactericidal for the facultative intracellular bacterium Listeria monocytogenes. Infect Immun (1988) 1.38
What is your diagnosis? Bilateral basilar femoral neck fractures in a dog. J Am Vet Med Assoc (1994) 1.38
Factors associated with chronic plantar heel pain: a systematic review. J Sci Med Sport (2006) 1.37
Modulation of macrophage tumoricidal capability by components of normal serum: a central role for lipid. Science (1977) 1.35
Migration inhibitory factor and type II interferon in the circulation of mice sensitized with mycobacterial components. J Immunol (1975) 1.33
Delayed hypersensitivity and granulomatous response after immunization with protein antigens associated with a mycobacterial glycolipid and oil droplets. J Immunol (1976) 1.31
In vitro nonimmunologic destruction of cells with abnormal growth characteristics by adjuvant activated macrophages. Proc Soc Exp Biol Med (1972) 1.30
Overuse tendinosis, not tendinitis part 1: a new paradigm for a difficult clinical problem. Phys Sportsmed (2000) 1.30
Patellar tendon ultrasonography and jumper's knee in female basketball players: a longitudinal study. Clin J Sport Med (1997) 1.28
Assembly and regulation of NADPH oxidase and nitric oxide synthase. Curr Opin Immunol (1994) 1.24
Growth inhibition of Cryptococcus neoformans by human alveolar macrophages. Am Rev Respir Dis (1987) 1.20
Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity. Infect Immun (1988) 1.19
Aconitases: a class of metalloproteins highly sensitive to nitric oxide synthesis. Methods Enzymol (1996) 1.19
Expression of the adenovirus E1A oncogene during cell transformation is sufficient to induce susceptibility to lysis by host inflammatory cells. Proc Natl Acad Sci U S A (1986) 1.19
Are unilateral and bilateral patellar tendinopathy distinguished by differences in anthropometry, body composition, or muscle strength in elite female basketball players? Br J Sports Med (2004) 1.18
Tumor regression caused by endotoxins and mycobacterial fractions. J Natl Cancer Inst (1975) 1.17
The macrophage as an antineoplastic surveillance cell: biological perspectives. J Reticuloendothel Soc (1978) 1.15
The role of nitrogen oxides as effector molecules of parasite killing. Parasitol Today (1990) 1.15
A new role for DNA virus early proteins in viral carcinogenesis. Science (1985) 1.14
Histopathology atlas of animal model systems - overview of guiding principles. Osteoarthritis Cartilage (2010) 1.14
Modulation of macrophage tumoricidal capability by polyene antibiotics: support for membrane lipid as a regulatory determinant of macrophage function. Proc Natl Acad Sci U S A (1978) 1.14
Macrophage-mediated fungistasis: requirement for a macromolecular component in serum. J Immunol (1986) 1.12
Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology. Infect Immun (1995) 1.11
Adjuvant induced resistance to tumor development in mice. Proc Soc Exp Biol Med (1972) 1.10
Patients with multidrug-resistant tuberculosis with low CD4+ T cell counts have impaired Th1 responses. J Immunol (1997) 1.10
Media-dependent subculture of nutritionally variant streptococci. Am J Clin Pathol (1981) 1.08
High strain mechanical loading rapidly induces tendon apoptosis: an ex vivo rat tibialis anterior model. Br J Sports Med (2005) 1.08
Antiparasitic effects of nitric oxide in an in vitro murine model of Chlamydia trachomatis infection and an in vivo murine model of Leishmania major infection. Immunol Ser (1994) 1.08